Starbloom Capital

Fickel's capital base was generated through early and substantial accumulation of Ethereum during the asset's formative years. While the exact basis and holding period are not publicly disclosed, on-chain records and industry reporting consistently identify Fickel as one of the earliest and largest individual Ethereum holders, and that position forms the permanent capital backing Starbloom's venture activities.

Both are vehicles of James Fickel. Starbloom Capital is the for-profit investment arm, while the Amaranth Foundation is a philanthropic entity that funds high-risk scientific research, notably at Harvard geneticist George Church's lab. The foundation does not invest for financial return; it makes grants. However, the entities operate with overlapping intellectual interests, and startups emerging from Church's lab have occasionally entered Starbloom's venture portfolio.

Starbloom appears to operate primarily as a proprietary capital vehicle for James Fickel, structured more as a single-family-style investment office than a traditional fund manager. There is no public record of the firm closing a third-party fundraise, maintaining limited partners, or registering as an investment adviser with the SEC.

The firm does not publicly commit to a stage mandate. Available evidence — early-stage privacy protocol 0xbow and pre-commercial biotech ventures — suggests a focus on pre-seed through Series A, with flexible check sizes enabled by a permanent-capital base. Follow-on capacity is supported by liquid on-chain holdings.

No explicit sector exclusions have been published by the firm. However, the observable portfolio is narrowly concentrated in two domains — blockchain infrastructure and deep-science biotech — and there is no record of investment in consumer internet, enterprise SaaS, fintech, or traditional industrials, suggesting these are outside Fickel's active mandate.

Vitalik Buterin has co-invested with Starbloom in at least one known deal: privacy infrastructure startup 0xbow. Other co-investors have not been systematically disclosed. The firm's network is concentrated in the Ethereum developer community and the Church lab biotech ecosystem, and those relationships serve as sourcing and syndication channels.

The Austin office at 100 Congress Avenue reflects the broader migration of technical talent and family office capital toward Texas during the early 2020s. It provides a secondary base outside San Francisco and positions the firm closer to the growing Texas crypto and biotech clusters, though the specific operational split between the two offices has not been publicly detailed.